Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:03:50.516Z.
Calculation as of: 2026-10-06T17:03:50.516Z.
Quote observation: 2026-10-06T17:00:53.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ed0d84ebe65fc765338e7baf7154c4548c52c7814b601df66b93f049f622236d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Prime Medicine, Inc.
Market Cap
$628.39M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$631.04M
Free Cash Flow Yield
N/A
TTM Avg
0.02%
3Y Avg
0.02%
5Y Avg
0.02%
Market Cap
$632.00M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$631.73M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$598.37M
Free Cash Flow Yield
31.01%
TTM Avg
16.53%
3Y Avg
24.36%
5Y Avg
19.94%
Market Cap
$598.08M
Free Cash Flow Yield
0.08%
TTM Avg
0.21%
3Y Avg
0.21%
5Y Avg
0.70%
Market Cap
$657.89M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$590.50M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prime Medicine, Inc. (PRME) | $628.39M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $631.04M | N/A | 0.02% | 0.02% | 0.02% |
| Aura Biosciences, Inc. (AURA)vs › | $632.00M | N/A | N/A | N/A | N/A |
| SOPHiA GENETICS S.A. (SOPH)vs › | $631.73M | N/A | N/A | N/A | N/A |
| OmniAb, Inc. (OABI)vs › | $648.75M | N/A | 0.14% | 0.13% | 0.13% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | 31.01% | 16.53% | 24.36% | 19.94% |
| AngioDynamics, Inc. (ANGO)vs › | $598.08M | 0.08% | 0.21% | 0.21% | 0.70% |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | N/A | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $590.50M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $587.75M | N/A | 2.13% | 14.68% | 12.04% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
